A CASE OF HIGH OUTPUT CARDIAC FAILURE IN A PATIENT WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA TREATED WITH BEVACIZUMAB

Hereditary Hemorrhagic Telangiectasia (HHT) is defined by recurrent epistaxis, cutaneous telangiectasia, and visceral arteriovenous malformations (AVM). Hepatic AVMs affect up to 74% of patients and these shunts can rarely cause high output cardiac failure (HOCF). We present a case of HHT and